CTRI/2017/12/010997已完成1 期
The Effect of Probiotic VSL#3 and Lifestyle Intervention in Obese Children with Non Alcoholic Fatty Liver Disease(NAFLD):A Randomized Clinical Trial - NA
Babe Ke Ayurvedic Hospital VPO Daudhar0 个研究点目标入组 106 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 106
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Obese children in age group of 5-18 years old with NAFLD
- •(BMI) >=95th or 85th to 94th percentile with risk factors
排除标准
- •Presence of liver disease due to hypothyroidism, wilson disease, viral hepatitis, cystic fibrosis, celiac disease, autoimmune hepatitis, drugs induced steatosis and gastrointestinal abnormalities.
研究者
相似试验
已完成
不适用
Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)Juvenile Idiopathic ArthritisNCT03092427Assistance Publique - Hôpitaux de Paris51
已完成
4 期
Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With CirrhosisCognitive DysfunctionCirrhosisNCT01686698Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau40
招募中
2 期
Role of a probiotic, VSL#3, in the prevention of spontaneous bacterial peritonitisCTRI/2008/091/000079Dept of Gastroenterology250
进行中（未招募）
不适用
To study the effect of probiotics in management of Poly cystic ovarian syndromeCTRI/2016/07/007086ICMR scholarship
已完成
不适用
Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to FibromyalgiaGastrointestinal DiseaseFibromyalgiaNCT04256785Elena Pita Calandre110